These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18804100)

  • 1. 1,5-anhydroglucitol monitoring in diabetes: a mass balance perspective.
    Nerby CL; Stickle DF
    Clin Biochem; 2009 Feb; 42(3):158-67. PubMed ID: 18804100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
    Stickle D; Turk J
    Am J Physiol; 1997 Oct; 273(4):E821-30. PubMed ID: 9357814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
    Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
    Won JC; Park CY; Park HS; Kim JH; Choi ES; Rhee EJ; Lee WY; Oh KW; Kim SW; Park SW
    Diabetes Res Clin Pract; 2009 Apr; 84(1):51-7. PubMed ID: 19187997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
    Su H; Ma X; Yin J; Wang Y; He X; Bao Y; Zhou J; Jia W
    Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
    Yamanouchi T; Akanuma Y
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S261-8. PubMed ID: 7859616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.
    Hess C; Stratmann B; Quester W; Madea B; Musshoff F; Tschoepe D
    Forensic Sci Int; 2012 Oct; 222(1-3):132-6. PubMed ID: 22749674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications.
    Xu H; Pan J; Chen Q
    Front Endocrinol (Lausanne); 2024; 15():1383483. PubMed ID: 38803475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational model of 1,5-AG dynamics during pregnancy.
    Zekavat SM; Butkovich S; Young GJ; Nathan DM; Petrasek D
    Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28821595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
    Yamanouchi T; Akanuma H; Nakamura T; Akaoka I; Akanuma Y
    Diabetologia; 1988 Jan; 31(1):41-5. PubMed ID: 3350220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system.
    Koga M; Murai J; Saito H; Mukai M; Kasayama S; Moriwaki Y; Yamamoto T
    Clin Chim Acta; 2009 Dec; 410(1-2):70-3. PubMed ID: 19781540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for the determination of 1,5-anhydroglucitol, a glycemic marker, in human urine utilizing hydrophilic interaction liquid chromatography/MS(3).
    Onorato JM; Langish RA; Shipkova PA; Sanders M; Wang J; Kwagh J; Dutta S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 873(2):144-50. PubMed ID: 18760978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.
    Nowatzke W; Sarno MJ; Birch NC; Stickle DF; Eden T; Cole TG
    Clin Chim Acta; 2004 Dec; 350(1-2):201-9. PubMed ID: 15530479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance liquid chromatographic determination of 1,5-anhydroglucitol in human plasma for diagnosis of diabetes mellitus.
    Tanaka S; Nakamori K; Akanuma H; Yabuuchi M
    Biomed Chromatogr; 1992; 6(2):63-6. PubMed ID: 1638091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma anhydro-glucitol as a blood sugar control marker for impared glucose tolerance].
    Maeda R; Ito C
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():386-9. PubMed ID: 15779409
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of glycemic monitoring marker 1,5-anhydroglucitol in plasma by liquid chromatography-electrospray tandem mass spectrometry.
    Li S; Heng X; Sheng H; Wang Y; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):459-64. PubMed ID: 18930443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aging on plasma 1,5-anhydroglucitol levels in humans and rats.
    Funasako M; Taniji M; Fujimoto K; Ohata M; Higashimoto Y; Uetani K; Suruda T; Nakai S; Fujimoto H; Sakagami Y
    Diabetes Res Clin Pract; 1994 Aug; 25(1):35-41. PubMed ID: 7835210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic quantification of 1,5-anhydro-D-glucitol: evaluation and clinical application.
    Phillipou G; James SK; Frith RG; Farrant RK; Phillips PJ
    Clin Chem; 1994 Jul; 40(7 Pt 1):1322-6. PubMed ID: 8013107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE; Odawara M; Terauchi Y
    Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.